Abstract
The prevalence of response variability to clopidogrel in Iranian patients undergoing
elective percutaneous coronary intervention (PCI) with stenting, impleta has not been
fully investigated. We evaluated clopidogrel antiplatelet effects of 300 mg versus a 450
mg in open blind randomized clinical trial in a referral teaching hospital in Iran.
elective percutaneous coronary intervention (PCI) with stenting, impleta has not been
fully investigated. We evaluated clopidogrel antiplatelet effects of 300 mg versus a 450
mg in open blind randomized clinical trial in a referral teaching hospital in Iran.
Keywords
Fulltext
Full Text Available is PDF
References
-
1.
Full Text Available is PDF.
Copyright
© 2012, Multidisciplinary Cardiovascular Annals. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.